Recent pharmaceutical innovations have opened a new path for weight loss through drugs based on gut hormones such as GLP-1 ...

The reduction is welcome news for those just beginning treatment, as lower doses are typically prescribed in the early stages ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

GLP-1 receptors are a naturally occurring hormone your body produces. These hormones regulate appetite. Wegovy’s active ingredient is semaglutide, a type of GLP-1 receptor agonist. GLP-1 ...

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...